Novartis AG/ CH0012005267 /
| 6/18/2025 2:32:19 PM | Chg. -0.30 | Volume | Bid2:32:45 PM | Ask2:32:26 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 95.41CHF | -0.31% | 133,534 Turnover: 12.71 mill. |
95.38Bid Size: 64 | 95.44Ask Size: 47 | 188.55 bill.CHF | - | - |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 5.92 USD | -17.20% |
| EPS Diluted: | - USD | -17.32% |
| Revenues per Share: | 26.19 USD | 27.82% |
| Book Value per Share: | 22.30 USD | 8.83% |
| Cash Flow per Share: | 8.92 USD | 40.52% |
| Dividend per Share: | 3.96 USD | 1.41% |
| Total | in mill. | |
| Revenues: | 51,722.00 USD | 10.85% |
| Net Income: | 11,941.00 USD | -19.59% |
| Operating Cash Flow: | 17,619.00 USD | - |
| Cash and Cash Equivalents: | 11,459.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 19.75 | 16.61 |
| P/S Ratio: | 4.46 | 3.75 |
| P/BV ratio: | 5.24 | 4.41 |
| P/CF Ratio: | 13.11 | 11.02 |
| PEG: | -1.15 | -0.97 |
| Earnings Yield: | 5.06% | 6.02% |
| Dividend Yield: | 3.38% | 4.02% |
| Market Capitalization | ||
| Market Capitalization: | 188.55 bill. CHF | 176.27 bill. CHF |
| Free Float Market Cap.: | - CHF | - CHF |
| Market Cap. / Employee: | 2.48 mill. CHF | 2.32 mill. CHF |
| Shares Outstanding: | 1.96 bill. | |
Profitability
| Gross Profit Margin: | 75.20% |
| EBIT Margin: | 28.12% |
| Net Profit Margin: | 23.09% |
| Return on Equity: | 27.11% |
| Return on Assets: | 11.68% |
Financial Strength
| Liquidity I / Cash Ratio: | 39.94% |
| Liquidity II / Quick Ratio: | 65.81% |
| Liquidity III / Current Ratio: | 103.53% |
| Debt / Equity Ratio: | 132.13% |
| Dynam. Debt / Equity Ratio: | 330.33% |
Efficiency
| Employees: | 75,883 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 681,601.94 USD |
| Net Income / Employee: | 157,360.67 USD |
| Total Assets / Employee: | 1,347,416.42 USD |
| * Fiscal Year End: | 12/31/2024 |
| Accounting Standard: | IFRS |
| Currency: | USD |
